Hotpennystocknews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angeles, CA -- (SBWIRE) -- 02/05/2014 -- Hotpennystocknews.com issues special report on - Advanced Cell Technology (ACTC), Northstar Global Business Services, Inc.(OTCMKTS:MDIN)
Advanced Cell Technology (ACTC), is a biotechnology company developing cellular therapies for treating diseases that impact millions of people worldwide.
Helmed by Chairman and CEO Gary Rabin, ACT is currently conducting the only human embryonic stem cell (hESC)-based clinical trials: two Phase I/II trials in the US and one in Europe. Initial results from the two US trials were published earlier this year in The Lancet.
ACT is also focused on its Hemangioblast platform for treating blood and cardiovascular diseases, and its mesenchymal stem cell program. ACT’s patented "embryo-safe" technique for deriving hESCs without harming embryos was documented in Nature.
ACTC are trading at $0.0899 and is +36.71% from its 50-day Moving Average price of $0.0658 and +39.32% from its 200-day Moving Average price of $0.0645. The average trading volume is 10107100 shares and its market capitalization is $234.6M.
For Hot Stories, Daily News Of ACTC , Free Sign Up Here.
Northstar Global Business Services, Inc.(OTCMKTS:MDIN), owns and operates MedGen Health Products, a division set up to continue the company's original mission to manufacture, sell and license healthcare products, specifically to the market for alternative therapies (health self-care).
The Company's flagship product to date has been SNORenz(R), a throat spray which reduces or eliminates the sounds ordinarily associated with snoring. SNORenz(R) is free of artificial colors, flavors or preservatives. Its patented ingredients, technology and manufacturing process, delivers consistent and measured droplet spray mists directly to the back of the throat, lubricating the uvula and soft palate that vibrate with each breath. SNORenz was sold until 2008 through Direct Marketing (DRTV) and Direct to Consumer (DTC) programs by way of the company owned web sites, affiliate programs and various TV Commercials and Print advertising campaigns. The company also sold through retailers and wholesalers nationwide.
The Company also marketed Good Nights Sleep TM . Good Nights Sleep TM is a liquid throat spray formulation for sleep aide. The company has two versions of formulations, one is all natural and the other uses the popular diphenhydromine as an active ingredient, "Good Nights Sleep was the first spray liquid in this category to enter the US market. Although production of these products stopped in 2008, the company's new "MedGen Health Products" division has been recently formed to re-deploy sales of both products and continue with the development of new products in the same industry.
MDIN is very active today and traded between $0.0006 - 0.0009 with total traded volume of 8737660 shares. At a current price of 0.0007, MDIN is -0.0002 - -22.22% from the previous close of $0.0009.
For More Details 100 % free Sign Up Here.
Neither Hotpennystocknews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by Hotpennystocknews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.Hotpennystocknews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through Hotpennystocknews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in.
Read Full disclaimer at:http://www.hotpennystocknews.com/disclaimer.php
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)